sector overview:
neurodegenerative conditions

Powering Innovation in Cognitive Health

Accelerating breakthroughs in Alzheimer’s and neurological disorders through world-class science, cutting-edge research, and collaborative leadership.

Research Leadership

Leading the Fight Against Neurodegenerative Diseases

Indiana is at the forefront of Alzheimer’s and neurodegenerative research, fueling critical breakthroughs in diagnostics, drug development, and patient care. With nationally recognized institutions, industry partnerships, and consistent federal and philanthropic funding, the Hoosier state is advancing science and delivering hope for patients and families.

Centrally located. Globally connected.

From groundbreaking diagnostics and therapies to nationally recognized clinical trials, the state offers a powerful ecosystem for discovery and patient impact. Indiana’s institutions receive significant NIH investment and lead multi-institutional efforts to change the trajectory of memory and brain health.

  • $35M NIH grant to IU and Purdue for Alzheimer’s drug discovery

  • Over $382M in NIH/NIA research funding to Indiana institutions

  • IU leads global Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS)

  • IU’s Alzheimer’s Disease Research Center is one of only 37 NIH-designated centers

innovation infrastructure

A Collaborative Environment That Fuels Innovation

  • Collaborative trial infrastructure

  • Established biobanks and genetic registries at Indiana University

  • Statewide access to top-tier imaging, diagnostics, and data platforms

Anchor Institutions

Indiana’s research institutions form the backbone of a nationally recognized neurodegenerative ecosystem. With decades of investment and proven leadership in Alzheimer’s science, they offer deep expertise across discovery, clinical research, and care delivery.

Innovation Engines and Academic Partners

The state’s innovation ecosystem connects science, startups, and education to accelerate real-world impact. From translational research to workforce development, Indiana offers the tools to move ideas from lab to market.

engage with us

Accelerate Impact in Alzheimer’s and Neurological Care

  • Partner on Alzheimer’s-focused clinical trials

  • Co-invest in translational science programs through IBRI or Indiana University 

  • Support new therapeutics, diagnostics, and biomarker pipelines

  • Invest in the workforce—clinical, imaging, tech-enabled care

Connect with BioCrossroads

Whether you’re ready to invest, partner, or explore possibilities, we can help make the connections.

 

Indiana's Advancements in Alzheimer's and Neurodegenerative Diseases

Click the link to download our fast facts sheet and discover more about Indiana's growing capabilities in addressing neurological conditions.